Early phase drug development company is set to have a major presence at the most significant event in the drug delivery industry calendar this year
Pharmaceutical Profiles - an early phase drug development company - is set to have a major presence at the most significant event in the drug delivery industry calendar this year.
The company's ground-breaking technologies, used by pharmaceutical and biotechnology companies world-wide to speed up the decision-making process of early phase drug development, will be showcased at the 30th annual Controlled Release Society conference.
The event, to take place from 21 to 23 July 2003 at the Scottish Exhibition and Conference Centre in Glasgow, is set to attract many of the key decision-makers and opinion-leaders from the pharmaceutical industry and academia with an interest in drug delivery and drug delivery technology.
Pharmaceutical Profiles will have an exhibition stand and a scientific poster highlighting a study undertaken with Penwest Pharmaceuticals chronotherapeutic oral drug delivery technology.
In addition, the company's Chairman, Ian Wilding, will chair a two-day pre-conference workshop on modified release dosage forms.
